miscsubjectsautonomous operating environment
Evidence review

SS-31 (Elamipretide) for PPI Users: Mitochondrial Pathways and Drug Context

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-ppis`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-ppis

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-ppis/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-ppis/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-ppis/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-ppis/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have PPIs (omeprazole, etc.)

Long-term PPI use centers on acid suppression in the stomach. This reduces acid production but can lead to downstream effects on nutrient absorption and mucosal health. Observational data link extended use to deficiencies in vitamin B12, magnesium, and calcium. These shortfalls can impair cellular energy processes and tissue maintenance over time.

Mitochondria rely on adequate cofactors for ATP generation and antioxidant defense. When absorption dips, mitochondrial efficiency may decline in some contexts. One line of discussion notes that proton pumps exist in mitochondria too, raising the possibility of broader effects beyond the stomach, though this remains indirect. The net result is a potential imbalance where repair processes face extra hurdles while symptoms of reflux stay managed.

Why SS-31 (Elamipretide) might help you

  1. You are reading about PPIs (omeprazole, etc.) — what breaks down matters before any compound name.
  2. Therefore for you: If mitochondrial function is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

SS-31 concentrates in the inner mitochondrial membrane and binds cardiolipin. This stabilizes the membrane, limits electron leak, and lowers reactive oxygen species output. If PPI-related nutrient gaps or other stressors have added oxidative burden to your mitochondria, this binding step could support cleaner energy production. The logic chain runs: better cardiolipin interaction → improved electron transport chain efficiency → potentially more ATP available for cellular repair tasks that acid suppression alone does not address.

Why PPIs (omeprazole, etc.) matters for you

Drug: PPIs (omeprazole, etc.). What it does: Acid suppression; long-term mucosal and nutrient consequences. Therefore for you: This drug suppresses a signal (gastric acid) and reduces mechanical or symptomatic load on the esophagus and stomach. That suppression can trade off repair support by limiting nutrient uptake needed for mitochondrial and mucosal maintenance. The benefit is symptom control; the potential cost is slower resolution of underlying cellular strain if deficiencies accumulate.

How these fit together

Single-compound focus. SS-31 targets the mitochondrial layer. PPIs handle acid-related load through suppression. The two address different points: one supports energy machinery inside cells, the other manages the primary driver of reflux. No direct synergy data exists; any overlap would depend on whether mitochondrial stress from nutrient shifts is active in a given person.

What the evidence actually shows

Human data on SS-31 come from trials in primary mitochondrial myopathy and heart failure. One phase 1/2 dose-escalation study in adults with primary mitochondrial myopathy reported safety and some functional signals. A phase 3 trial (MMPOWER-3) followed. Results were mixed across programs; primary endpoints were not always met. Recent accelerated approval occurred for Barth syndrome based on muscle strength data from the TAZPOWER trial. No human trials examine SS-31 in people taking PPIs.

Preclinical work shows SS-31 improves mitochondrial respiration and reduces oxidative damage in aged or stressed rodent models, including kidney and cardiac tissue. These are animal findings and do not prove effects in PPI users.

For PPIs, large observational cohorts associate long-term use with nutrient deficiencies and renal risks. No randomized data prove causation for mitochondrial outcomes.

What scientists say

Researchers describe SS-31 as a cardiolipin stabilizer that concentrates in mitochondria regardless of disease state. Reviews note consistent preclinical benefits on ROS and ATP but emphasize that clinical translation has been narrower than hoped. On PPIs, gastroenterology literature stresses short-term safety while flagging monitoring needs for deficiencies with prolonged use.

What people say on Reddit

Anecdotal reports on SS-31 appear in communities focused on chronic fatigue or mitochondrial topics. One user described starting at low doses and noting initial fatigue and GI shifts that later eased with dose adjustment; another reported increased energy. These are individual experiences, not controlled observations, and no posts directly reference concurrent PPI use.

What people say on X

Public posts discussing SS-31 and PPIs together are not prominent in available searches. Limited mentions of either compound appear separately, with no clear crossover anecdotes surfacing.

What we do not know

No studies test whether SS-31 alters outcomes in PPI users. The mitochondrial-proton pump connection suggested in some commentary lacks direct measurement. Long-term nutrient effects of PPIs on mitochondrial markers remain unquantified in interventional designs.

Safety and limits

SS-31 has shown an acceptable profile in completed human trials, with mild injection-site reactions noted most often. PPIs carry well-documented risks with extended use, primarily around absorption and infection susceptibility. Any combination remains unstudied. Evidence tiers here stay mechanistic or preclinical for the cross; human data are absent for the specific pairing.

PARTIAL 4/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 4 claims are extracted and stored on the object.
  • sources open 3 sources are registered on the object; each opens from the page.
  • claims bound 3 of 4 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

2 declared gaps. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/ss-31-ppis/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/ss-31-ppis/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

ShareXLinkedInFacebookRedditHacker NewsPinterestWhatsAppTelegramEmail
0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key 
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/ss-31-ppis?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/ss-31-ppis/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

PPIs · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedSS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence… · 2 humanSS-31 (Elamipretide) for Carpal Tunnel Syndrome: Mitochondrial Evidenc… · 2 humanSS-31 (Elamipretide) for Chemotherapy Side Effects: Mitochondrial Evid… · 2 humanSS-31 (Elamipretide) for Chemotherapy-Induced Neuropathy: Evidence Rev… · 2 human
Evidence · 3 sources · swipe →chain a6893a6ccdaf · verify chain · provenance
1 / 3

Key evidence

4 claims · tier-ranked · API
human
Long-term PPI use is associated with vitamin B12, magnesium, and calcium deficiencies in observational data.
sources: s1
preclinical
SS-31 binds cardiolipin in the inner mitochondrial membrane and reduces ROS in preclinical models.
sources: s2
mechanistic
No human trials examine SS-31 in PPI users.
humanlow confidence
Human trials of SS-31 exist for primary mitochondrial myopathy and heart failure with mixed primary endpoint results; recent approval for Barth syndrome.
sources: s3
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:48
SS-31 (Elamipretide) for PPI Users: Mitochondrial Pathways and Drug Context · 4 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Ppis
Slug: ss-31-ppis
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"PPIs (omeprazole, etc.)","condition_key":"ppis","primary_peptide":"ss-31","peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":["ppis"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down if yo
it output
{
  "slug": "ss-31-ppis",
  "title": "SS-31 (Elamipretide) for PPI Users: Mitochondrial Pathways and Drug Context",
  "body": "## What's breaking down if you have PPIs (omeprazole, etc.)\n\nLong-term PPI use centers on acid suppression in the stomach. This reduces acid production but can lead to downstream effects on nutrient absorption and mucosal health. Observational data link extended use to deficiencies in vitamin B12, magnesium, and calcium. These shortfalls can impair cellular energy processes and tissue maintenance over time.\n\nMitochondria rely on adequate cofactors for ATP generation and antioxidant defense. When absorption dips, mitochondrial efficiency may decline in some contexts. One line of discussion notes that proton pumps exist in mitochondria too, raising the possibility of broader effects beyond the stomach, though this remains indirect. The net result is a potential imbalance where repair processes face extra hurdles while symptoms of reflux stay managed.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about PPIs (omeprazole, etc.) — what breaks down matters before any compound name.\n2. Therefore for you: If mitochondrial function is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 concentrates in the inner mitochondrial membrane and binds cardiolipin. This
2f141ff249fa2595
Machine verification: /api/articles/ss-31-ppis/contributions

Latest from the journal

Most recent pieces, site-wide

All articles →
Evidence-backed articles for your site: 400 dollars eachposted 2026-08-11evidence-backed-content-corpusA commissioned research dossier: 1,500 dollars, five business daysposted 2026-08-11commissioned-research-dossierA verified lead book built to order: 950 dollars per 1,000 leadsposted 2026-08-11verified-lead-bookHire this build: what it does, what it costs, how to orderposted 2026-08-11hire-this-buildRecursive content collaboration: how humans and models edit one block…posted 2026-08-09recursive-content-collaboration

Related articles

PPIs · drug map

Open evidence map →
Ss 31ss-31SS-31 (Elamipretide) for Benzodiazepine Withdrawal: Mitochondrial Repa…ss-31-benzo-withdrawalSS-31 (Elamipretide) and Benzodiazepines: Mitochondrial Pathways in a…ss-31-benzodiazepinesSS-31 (Elamipretide) and Statin-Associated Cognitive Effects: Evidence…ss-31-brain-fogSS-31 (Elamipretide) for Carpal Tunnel Syndrome: Mitochondrial Evidenc…ss-31-carpal-tunnelSS-31 (Elamipretide) for Chemotherapy Side Effects: Mitochondrial Evid…ss-31-chemo
Ask this article · 6 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Long-term PPI use is associated with vitamin B12, magnesium, and calcium deficiencies in observational data."?
ask ss-31-ppis claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "SS-31 binds cardiolipin in the inner mitochondrial membrane and reduces ROS in preclinical models."?
ask ss-31-ppis claim c2 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "No human trials examine SS-31 in PPI users."?
ask ss-31-ppis claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "Human trials of SS-31 exist for primary mitochondrial myopathy and heart failure with mixed primary endpoint results; recent approval for Ba…"?
ask ss-31-ppis claim c3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 (Elamipretide) for PPI Users: Mitochondrial Pathways and Drug Context — and what would you need me to tell you first?
ask ss-31-ppis condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 (Elamipretide) for PPI Users: Mitochondrial Pathways and Drug Context (studies vs anecdotes)?
ask ss-31-ppis good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Fss-31-ppis%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/ss-31-ppis/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/ss-31-ppis/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3